Skip to content
Govbase
Govbase
Congress·In Committee·H.R. 7980

Protecting Americans from Unsafe Drugs Act of 2026

Rep. Dexter Introduces Bill Giving FDA Power to Recall All Dangerous Drugs

This bill is currently in the early stages of the legislative process after being sent to the House Committee on Energy and Commerce. It is actively moving through the system, but no future hearings or votes have been scheduled yet. There is no companion bill mentioned at this time.

Legislative Progress

House
Senate
President
Law
Unlikely to pass

Most bills introduced in the House do not make it past the committee stage unless they have a large number of supporters from both parties.

Key Points

Healthcare

Impact Analysis

Personal Impact

Life & Work

Small pharmaceutical manufacturers and compounding pharmacies could face new compliance burdens if the FDA exercises expanded mandatory recall authority against their products. While current voluntary recall systems often work, mandatory recall orders could impose sudden costs on small drug makers. On the other hand, the expanded authority also levels the playing field by ensuring all competitors meet the same safety standards.

2
2
1
5
0
ImpactCertaintyScopeDurationSentiment

Disabilities

Milestones

2 milestones2 actions
Mar 18, 2026House

Referred to the House Committee on Energy and Commerce.

Mar 18, 2026

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Protecting Americans from Unsafe Drugs Act of 2026

Bill NumberHR 7980
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Energy and Commerce.

Sponsor

Analysis generated by AI. Always verify with official sources.